Auspex Pharmaceuticals Inc (NASDAQ:ASPX)

Data as of Jan 28
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Auspex Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. Its pipeline includes product candidates to address unmet medical needs in hyperkinetic movement disorders, such as chorea associated with huntington's disease, an orphan disease, and tardive dyskinesia and tourette syndrome, subsets of either of which may be deemed to be orphan diseases, as well as other orphan indications. The company uses unique properties of deuterium to develop a pipeline of innovative drugs in several important disease areas. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in La Jolla, CA.

Contact Information

Auspex Pharmaceuticals, Inc.
3366 North Torrey Pines Court
La Jolla California 92037
P:(858) 558-2400
Investor Relations:
(858) 875-5896



Individual stakeholders52.11%
Mutual fund holders23.20%
Other institutional23.17%

Top Executives

Bharat M. ChowriraCOO & Head-Business Development
John P. SchmidChief Financial Officer & Head-Investor Relations
Andreas SommerSecretary & Vice President-Research
David A. StamlerChief Medical Officer
Samuel R. SaksDirector & Chief Development Officer

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.